Home
Library and Tools
Introduction to Library
Mutual Fund Investing Guide
Membership
Subscribe
Contact us
Fund Ratings
Fidelity
Fidelity 401k
Vanguard
Vanguard 401k
News & Outlook
MFA Outlook
Market Outlook
Fidelity News
Vanguard News
Other Fund News
test_iframe
tear sheet
Login
Home
Library and Tools
Introduction to Library
Mutual Fund Investing Guide
Membership
Subscribe
Contact us
Fund Ratings
Fidelity
Fidelity 401k
Vanguard
Vanguard 401k
News & Outlook
MFA Outlook
Market Outlook
Fidelity News
Vanguard News
Other Fund News
test_iframe
tear sheet
Mutual Fund News
27
Loans against mutual funds: Is it better than personal loans?
Editor
posted on March 27, 2024 21:42
Borrowers are always looking at better ways of getting loans in hopes of avoiding higher interest rates and saving on money.Among these alternatives, loans secured against mutual funds are gaining ...
[Read the rest of this article...]
Posted in:
Other Fund News
Actions:
E-mail
|
Permalink
|
27
Are You A Mutual Fund Investor? Know Why March 31 Is Crucial
Editor
posted on March 27, 2024 21:37
Mutual fund investors need to submit authorised documents for KYC so that they can continue with their investments.
[Read the rest of this article...]
Posted in:
Other Fund News
Actions:
E-mail
|
Permalink
|
27
March 31 is the deadline to redo mutual fund KYC: Here's who needs to act and how
Editor
posted on March 27, 2024 20:09
To determine whether re-KYC is necessary, investors should consult the CVL KRA website or contact mutual fund houses or RTA helplines.
[Read the rest of this article...]
Posted in:
Other Fund News
Actions:
E-mail
|
Permalink
|
27
3 out of 4 mid and smallcap mutual funds underperformed in 2023: Report
Editor
posted on March 27, 2024 19:57
Around 30% of Indian ELSS funds have underperformed against their benchmark S&P BSE 200. The ELSS fund category is the only category where the majority of funds outperformed their relevant benchmarks ...
[Read the rest of this article...]
Posted in:
Other Fund News
Actions:
E-mail
|
Permalink
|
27
SEBI asks mutual funds why elderly citizens were sold small-cap schemes
Editor
posted on March 27, 2024 19:00
SEBI has asked at least one fund house why super senior citizens were sold high-risk schemes like small-cap schemes. Industry says more mutual funds have got SEBI’s email.
[Read the rest of this article...]
Posted in:
Other Fund News
Actions:
E-mail
|
Permalink
|
27
Last minute tax saving idea: Can ELSS mutual funds fit into your portfolio?
Editor
posted on March 27, 2024 18:06
ELSS or tax-saving schemes are benchmarked against Nifty 500 - TRI, S&P BSE 500 - TRI, S&P BSE 100 - TRI. Nifty 500 - TRI, S&P BSE 500 - TRI gave 19.30% each, and S&P BSE 100 - TRI gave 17.59%.
[Read the rest of this article...]
Posted in:
Other Fund News
Actions:
E-mail
|
Permalink
|
27
Interest rate, demand drive up investments in Mutual Funds to N2.8trn
Editor
posted on March 27, 2024 12:01
Mutual fund is a collective investment platform that pools funds from investors and managed professionally by investing in choice money and capital market assets. Vanguard’s findings from the latest ...
[Read the rest of this article...]
Posted in:
Vanguard News
Actions:
E-mail
|
Permalink
|
27
2 Stock Market Crash Triggers Loom on March 29. Be Warned.
Editor
posted on March 27, 2024 11:27
Fears of a stock market crash are swirling ahead of two major potential triggers coming this Friday, March 29. Indeed, the Federal Reserve’s favorite inflation gauge releases Friday morning, preceding ...
[Read the rest of this article...]
Posted in:
Market Outlook and Commentary
Actions:
E-mail
|
Permalink
|
27
Fidelity registers for spot Ethereum ETF
Editor
posted on March 27, 2024 07:17
Fidelity Investments (Fidelity) has filed a registration with the United States Securities and Exchange Commission (SEC) to apply for a spot Ethereum (ETH) exchange-traded fund (ETF). Notably, the ...
[Read the rest of this article...]
Posted in:
Fidelity News
Actions:
E-mail
|
Permalink
|
27
Merck Stock Soars On FDA Approval for Winrevair: Technical Analysis And Market Outlook
Editor
posted on March 27, 2024 07:00
Merck & Co Inc (NYSE:MRK) recently received regulatory approval for Winrevair (sotatercept), a groundbreaking therapy for adults with pulmonary arterial hypertension (PAH). This approval marks a ...
[Read the rest of this article...]
Posted in:
Market Outlook and Commentary
Actions:
E-mail
|
Permalink
|
Page 1 of 7
First
Previous
[1]
2
3
4
5
6
7
Next
Last
Current Articles
|
Archives
|
Search
News Archive
News Archive
March 2024 (59)
February 2024 (4)
January 2024 (1)
November 2022 (2)
Fidelity Fund Ratings
Growth
Balanced
Income
International
Asset Allocation
Fidelity Sector
Fidelity 401k Fund Ratings
Growth
Balanced
Income
International
Asset Allocation
Vanguard Fund Ratings
Growth
Balanced
Income
International
Asset Allocation
Sector
Vanguard 401k Fund Ratings
Growth
Balanced
Income
International